<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00065624</url>
  </required_header>
  <id_info>
    <org_study_id>R21AT001062-01A2</org_study_id>
    <nct_id>NCT00065624</nct_id>
  </id_info>
  <brief_title>Antioxidant Functions of Lipoic Acid</brief_title>
  <official_title>Antioxidant Functions of Lipoic Acid</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Center for Complementary and Integrative Health (NCCIH)</agency>
      <agency_class>NIH</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>National Center for Complementary and Integrative Health (NCCIH)</source>
  <brief_summary>
    <textblock>
      The goal of this study is to determine whether a short treatment with lipoic acid, an
      antioxidant used in the treatment of diabetic neuropathy, improves blood vessel reactivity
      and decreases oxidant stress in persons with elevated blood cholesterol.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      As per Brief Summary
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>November 2003</start_date>
  <completion_date type="Actual">July 2007</completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double</masking>
  </study_design_info>
  <enrollment>16</enrollment>
  <condition>Hypercholesterolemia</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>lipoic acid</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion criteria:

          -  Lipid criteria for inclusion are a plasma LDL between 160 and 190 mg/dl (total
             cholesterol usually 240-285 mg/dl)

          -  Less than 2 coronary risk factors, and already on a cholesterol-lowering diet.

        Exclusion criteria:

          -  Overt or clinical atherosclerosis

          -  Diabetes

          -  Currently taking cholesterol-lowering medication.

          -  Subjects with other lipid disorders

          -  Subjects taking supplemental lipoic acid, vitamin C, or vitamin E.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>James M May, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Vanderbilt University Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Vanderbilt University Medical Center</name>
      <address>
        <city>Nashville</city>
        <state>Tennessee</state>
        <zip>37232</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2007</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 29, 2003</study_first_submitted>
  <study_first_submitted_qc>July 30, 2003</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 31, 2003</study_first_posted>
  <last_update_submitted>September 28, 2007</last_update_submitted>
  <last_update_submitted_qc>September 28, 2007</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 2, 2007</last_update_posted>
  <keyword>Lipoic acid</keyword>
  <keyword>F2-isoprostanes</keyword>
  <keyword>endothelial dysfunction</keyword>
  <keyword>natural product</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypercholesterolemia</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Antioxidants</mesh_term>
    <mesh_term>Thioctic Acid</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

